New mRNA flu vaccine shows promise: Faster to produce, highly effective in mice

The study evaluates the efficacy of a new quadrivalent mRNA influenza vaccine, finding it to be highly immunogenic and protective in a mouse model. Compared to traditional vaccines, the mRNA-based option offers advantages like reduced production time and elimination of the risk of growth-promoting mutations.

Accenture invests in biotechnology company Earli to advance cancer technologies

The synthetic biopsy method is designed to improve the sensitivity and specificity of cancer detection. Credit: Chinnapong/Shutterstock. Accenture has invested in biotechnology company Earli to

August 20, 2024

Avadel’s narcolepsy drug Lumryz misses PDUFA date, still under review at FDA

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 13, 2024

Alpha-Gal May Drive Sensitivity to IV Stelara in People With Red-Meat Allergies

ORLANDO — First-dose reactions to IV ustekinumab (Stelara) may be related to IgE recognition of a carbohydrate allergen in patients, who may be able to

December 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.